TC BioPharm (Holdings) plc Warrants (TCBPW) Peer Comparison

$0.01

$0.00 (-38.14%)

As on 21-Mar-2025 16:25EDT

Market cap

$-- Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Edit

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Market cap ($ Mln)	--	907
Revenue (£ Mln)	--	1
Net Profit (£ Mln)	-5.91	-59.95
Net Margin (%)	--	-9,759.23
RoE (%)	-391.64	-118.98
Price to Earnings	--	--
Price-To-Book	--	23.89

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (£ Mln)

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Operating Revenue	0.00	25.38
Cost of Revenue	--	10.32
Gross Profit	--	15.06
Operating Expenses	6.91	64.66
Operating Profit (EBIT)	-14.24	-49.60
Other Income	--	--
Profit before Tax	-7.00	-50.31
Provision for Tax	-1.09	-7.04
Profit after Tax (Net Income)	-5.91	-43.27
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities (£ Mln)

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Shareholder's Funds	2.69	21.99
Minority Interest	--	--
Non-Current Liabilities	1.50	59.45
Current Liabilities	4.75	17.68
Total Liabilities	8.93	94.53

Assets (£ Mln)

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Non-Current Assets	3.23	12.90
Current Assets	5.70	81.63
Total Assets	8.93	119.45
Total Debt*	1.80	0.27
Net Current Assets	0.95	63.25

Cashflow (£ Mln)

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Cash From Operating Activities	-10.54	-39.35
Cash Flow from Investing Activities	-0.21	16.43
Cash from Financing Activities	8.52	25.16
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
ROCE (%)	-162.55	-193.22
ROE (%)	-391.64	-196.38
ROA (%)	-58.42	-42.83
EBIT Margin (%)	--	--
Net Margin (%)	--	-170.51
Cash Profit Margin (%)	--	--

Growth Ratios

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Revenue Growth (%)	-1.00	0.44
EBIT Growth (%)	--	--
Net Profit Growth (%)	-349.68	-5.45
EPS Growth (%)	-16.72	0.04
Book Value Growth (%)	--	--

Valuation Ratios

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Price / Earnings	-0.02	-5.30
Price / Book Value	0.04	10.43
Dividend Yield (%)	--	--
EV/EBITDA	0.04	-3.52
Market Cap ($ Cr)	--	--

Solvency Ratios

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Debt to Equity	0.67	0.01
Short term debt to equity ratio	0.11	0.01
Current Ratio	1.20	4.62
Quick Ratio	1.46	5.67
Interest Coverage	-171.51	-1,478.71

Operating Efficiency Ratios

	TC BioPharm (Holdings) plc Warrants (TCBPW)	Silence Therapeutics PLC (SLN)
Debtors to sales (%)	--	74.78
Asset Turnover	0.00	0.25
Receivable days	--	143.14
Inventory Days	--	-620.05
Payable days	--	103.29
Cash Conversion Cycle	--	-580.20

Annual
Quarterly